Zoetis | ZTS - Sales Revenues



Zoetis reported $2.46B in Sales Revenues for its fiscal quarter ending in June of 2025.


Sales Change Date
AbbVie USD 15.42B 2.08B Jun/2025
Align Technology USD 1.01B 30.7M Jun/2025
Bayer EUR 10.74B 3B Jun/2025
Bristol-Myers Squibb USD 12.27B 1.07B Jun/2025
Charles River Laboratories USD 1.03B 45.8M Jun/2025
Dentsply International USD 936M 57M Jun/2025
Eli Lilly USD 15.56B 2.83B Jun/2025
Henry Schein USD 3.2B 30M Jun/2025
Idexx Laboratories USD 1.11B 111.57M Jun/2025
Illumina USD 1.06B 20M Jun/2025
IQVIA Holdings USD 4.02B 190M Jun/2025
J&J USD 23.74B 1.85B Jun/2025
Laboratory Of America USD 3.53B 180M Jun/2025
Merck USD 15.81B 280M Jun/2025
Neogen USD 225.5M 4.5M May/2025
Pacira USD 181.1M 12.18M Jun/2025
Perrigo USD 1.06B 20M Jun/2025
Pfizer USD 14.7B 980M Jun/2025
Quest Diagnostics USD 2.76B 110M Jun/2025
Sanofi EUR 9.99B 90M Jun/2025
Sanofi EUR 10.74B 529.51M Jun/2025
Zoetis USD 2.46B 240M Jun/2025